Artiva Biotherapeutics Statistics

Total Valuation

ARTV has a market cap or net worth of $271.77 million. The enterprise value is $445.98 million.

Market Cap	271.77M
Enterprise Value	445.98M

Important Dates

The next estimated earnings date is Friday, November 22, 2024, before market open.

Earnings Date	Nov 22, 2024
Ex-Dividend Date	n/a

Share Statistics

ARTV has 24.29 million shares outstanding. The number of shares has increased by 5.55% in one year.

Shares Outstanding	24.29M
Shares Change (YoY)	+5.55%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.26%
Owned by Institutions (%)	8.69%
Float	4.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.30
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	15.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.59, with a Debt / Equity ratio of 0.62.

Current Ratio	4.59
Quick Ratio	4.44
Debt / Equity	0.62
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	$680,372
Profits Per Employee	-$756,395
Employee Count	43
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ARTV has paid $72,000 in taxes.

Income Tax	72,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	12.32
200-Day Moving Average	n/a
Relative Strength Index (RSI)	45.57
Average Volume (20 Days)	69,997

Short Selling Information

The latest short interest is 940,524, so 3.87% of the outstanding shares have been sold short.

Short Interest	940,524
Short Previous Month	840,866
Short % of Shares Out	3.87%
Short % of Float	23.38%
Short Ratio (days to cover)	3.53

Income Statement

In the last 12 months, ARTV had revenue of $29.26 million and -$32.53 million in losses. Loss per share was -$40.19.

Revenue	29.26M
Gross Profit	29.26M
Operating Income	-31.84M
Pretax Income	n/a
Net Income	-32.53M
EBITDA	-29.50M
EBIT	-31.84M
Loss Per Share	-$40.19

Full Income Statement

Balance Sheet

The company has $46.56 million in cash and $15.77 million in debt, giving a net cash position of $30.79 million or $1.27 per share.

Cash & Cash Equivalents	46.56M
Total Debt	15.77M
Net Cash	30.79M
Net Cash Per Share	$1.27
Equity (Book Value)	25.32M
Book Value Per Share	-234.70
Working Capital	38.92M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$50.19 million and capital expenditures -$1.30 million, giving a free cash flow of -$51.49 million.

Operating Cash Flow	-50.19M
Capital Expenditures	-1.30M
Free Cash Flow	-51.49M
FCF Per Share	-$2.12

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -108.84% and -111.17%.

Gross Margin	100.00%
Operating Margin	-108.84%
Pretax Margin	-110.93%
Profit Margin	-111.17%
EBITDA Margin	-100.84%
EBIT Margin	-108.84%
FCF Margin	n/a

Dividends & Yields

ARTV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.55%
Shareholder Yield	-5.55%
Earnings Yield	-12.49%
FCF Yield	-19.78%

Analyst Forecast

The average price target for ARTV is $21.25, which is 89.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.25
Price Target Difference	89.90%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ARTV has an Altman Z-Score of -4.31 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.31
Piotroski F-Score	1